News

Prostate Cancer Diagnostics and Therapy Market 2019-2024 Comprehensive Analysis of Leading Key Players with Significant Growth Rate and Gross Margin Forecast to 2024

Press Release

Prostate Cancer Diagnostics and Therapy

Prostate Cancer Diagnostics and Therapy Market” report 2019-2024 provides detailed summary of company competition, market demand, regional forecast, marketing price and new investment feasibility analysis is included of Prostate Cancer Diagnostics and Therapy market. It also covers approximate CAGR, key-players, scope of the report, regional analysis, major market factors of Prostate Cancer Diagnostics and Therapy market, reasons of buying this report and complete TOC of report.

Request a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244650

There are 4 key segments covered in this Prostate Cancer Diagnostics and Therapy Systems Market report:

  • Competitor segment
  • Product type segment
  • End-use/application segment
  • Geography segment

Market Overview:

  • The prostate cancer diagnostics and therapy market is expected to register a CAGR of nearly 6.1% during the forecast period, 2019-2024.
  • – The major factor driving the growth of the market studied is aging population and high prevalence rate of prostate cancer. Prostate cancer is the second most common type of cancer in male population. About 80% of men who reach 80 years of age are diagnosed with it.
  • – As per the estimates provided by the American Cancer Society, in 2018, the United States is expected to witness over 164,690 new cases of prostate cancer, with over 29,430 related deaths. Nearly 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. One in every nine men is expected to be diagnosed with prostate cancer during his lifetime.
  • – In addition, according to the United States Census Bureau’s Statistics, the total number of people aged 65 and older exceeds 50 million as of 2017, and the number of elderly is projected to increase by almost 18 million during 2020-2030. The number of people aged 85 and older is expected to triple from an estimated 6 million of today to nearly 20 million, by 2060. The risk of developing prostate cancer increases significantly with age, and rise in geriatric population is one of the leading factors that contribute to the expansion of the mar

    Prostate Cancer Diagnostics and Therapy Market by Key Players:

  • Ipsen SA
  • Bayer AG
  • Astellas Pharma Inc.
  • Abbvie Inc.
  • Dendreon Pharmaceuticals LLC
  • AstraZeneca PLC
  • Sanofi
  • Aventis
  • Tolmar Inc.
  • Koninklijke Philips NV
  • Hologic Inc.

    Enquire Before Purchasing this Report https://www.industryresearch.co/enquiry/pre-order-enquiry/14244650

    Scope of the Report:

  • The prostate gland is located in the pelvis, below the bladder and in front of the rectum. Prostate cancer begins when normal cells in the prostate begin to multiply uncontrollably. The scope of the study is limited to revenue generated by various diagnostic and therapeutic products used in the management of benign prostatic hyperplasia, prostatic adenocarcinoma, and small cell carcinoma, among other types of prostate cancer.

    Key Market Trends:

    The Prostate-specific Antigen (PSA) Testing Segment is Expected to Grow at Rapid Pace.

    Prostate-specific Antigen (PSA) is a protein produced by prostate cells. Therefore, the PSA test is performed to diagnose prostate cancer (PCa) in men and for follow-up post treatment to check if the cancer relapses. PSA testing is an important tool for detecting prostate cancer, which measures the level of PSA in a man’s blood. Medicare and several private insurers provide coverage for an annual PSA test for all Medicare-eligible men aged 50 and older. The PSA testing is gaining popularity among clinicians and hospitals, owing to the increasing number of people being affected by prostate cancer. It has more market value in the countries with high prevalence rate (Western) and low prevalence rate (Asian), as PSA is used globally for the early detection/screening of prostate cancer.

    PSA testing is anticipated to reduce the likelihood of death from prostate cancer. Refinements of the prostate-specific antigen (PSA) test have been developed to reduce the number of false positive results. Therefore, due to the rising prevalence of prostate cancer, the market is expected to witness high growth rate, over the forecast period.

    United States is Expected to Retain the Largest Market Share During the Period of Forecast.

    Prostate cancer is considered as one of the most common cancers among American men, and more than 60% of all prostate cancers are diagnosed in men older than 65. According to the American Cancer Society’s, 2019, there are about 174,650 new cases of prostate cancer accounting for 31,620 deaths. Hence, it is considered to have an early diagnosis of the condition. In case of the treatment, the early stages of prostate cancer are treated by radiation therapy and for the late stages, where it has spread beyond the prostate gland, hormone therapy, chemotherapy, and or immunotherapy treatments, are recommended. In the case of benign prostatic hyperplasia (BPH), resectoscopy is the major treatment procedure. Zytiga and Xtandi are the major therapeutics that are used for treatment. Zytiga is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). With promising pipeline drugs, such as Apalutamide, the market of therapeutics is expected to increase.

    Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14244650

    Prostate Cancer Diagnostics and Therapy Market Covers Following Points in TOC:

    • Chapter 1: Prostate Cancer Diagnostics and Therapy Market Definition
    • Chapter 2: Research Methodology of Prostate Cancer Diagnostics and Therapy Market
    • Chapter 3: Prostate Cancer Diagnostics and Therapy Market Executive Summary
    • Chapter 4: Prostate Cancer Diagnostics and Therapy Market Overview Includes Current Market Scenario, Porter’s Five Forces Analysis, Bargaining Power of Suppliers and Consumers, Threat of New Entrants and Substitute Product and Services
    • Chapter 5: Market Dynamics Covers Drivers, Restraints, Opportunities and Challenges
    • Chapter 6: Prostate Cancer Diagnostics and Therapy Market Segmentation by Types, End-User, and Applications Forecast to 2024
    • Chapter 7: Prostate Cancer Diagnostics and Therapy Market Segmentation by Geographical Regions
    • Chapter 8: Competitive Landscape of Prostate Cancer Diagnostics and Therapy Market Includes Mergers & Acquisition Analysis, Agreements, Collaborations, and Partnerships, New Products Launches
    • Chapter 9: Key Players for Prostate Cancer Diagnostics and Therapy Market

    Report PageProstate Cancer Diagnostics and Therapy Market – Growth, Trends, and Forecast (2019 – 2024)

     

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]earch.co

  • RSS news